Skip to Content

Vi dækker

ASH | American Society of Hematology Meeting & Exposition

ASH 2025

Astrid Hundeboell Torpe

ASH 2025: Prophylactic Tocilizumab Reduces CRS

december 2025 / Astrid Hundebøll Torpe

ASH25 Multiple myeloma

ASH 2025 Highlights – Nordic Webinar 11 December

11. december 2025

Stay up to date with the most relevant findings and developments presented at ASH 2025. Our experts will highlight key clinical data, emerging treatment strategies, and their potential impact on patient care. Join the live session or watch it on demand at your convenience.

ASH 2024

Advancing Towards New Treatment Options for AML

februar 2025 / Jan Andreasen

Even Though There Was Little Game-Changing Data, ASH 2024 Provided a Valuable Overview of the Future of Hematology Treatment Across Our Diseases

februar 2025 / Jan Andreasen

ASH24

Hematology

Meet the Experts
2024

Get access

Key Findings That Could Transform Multiple Myeloma Treatment

februar 2025 / Hæmatologi / Jan Andreasen

CLL: Encouraging Results and The Balance Between Deep Response and Side Effects

februar 2025 / Hæmatologi / Jan Andreasen

Ingen ændringer i behandlingen inden for lymfom efter ASH 2024, men mange vigtige updates

januar 2025 / Hæmatologi / Tarec Christoffer El-Galaly

ASH 2024: Nyt om AML i dansk perspektiv

januar 2025 / Hæmatologi / Hans Beier Ommen

Dansk Aften ASH 2024: Nye fremskridt i behandling af CLL

januar 2025 / Hæmatologi / Emelie Hamotal Curovic Rotbain

Back to top